Literature DB >> 20056110

The mitogaligin protein is addressed to the nucleus via a non-classical localization signal.

Pauline Robinet1, Lucile Mollet, Patrick Gonzalez, Thierry Normand, Stéphane Charpentier, Fabienne Brulé, Martine Dubois, Alain Legrand.   

Abstract

Mitogaligin, a protein encoded by galig, an internal cytotoxic gene of the galectin-3 locus, is mostly a mitochondrial protein. Mitochondrial targeting is due to an already identified mitochondrial localization signal. Interaction of mitogaligin with mitochondria leads to cytochrome c cytosolic leakage and ultimately to cell death. We have previously pointed out that mitogaligin can also be directed to the nucleus when the mitochondrial addressing signal is inactivated, indicating a possible dual intracellular localization of the protein. When expressed in the nucleus, mitogaligin exhibits also apoptotic properties leading to cell death. In this report, we show that nuclear addressing of mitogaligin depends on a sequence differing from classical signals containing basic, lysine or proline-tyrosine rich residues. The signal consists of a long sequence of amino acids residues based on a series of a short repetitive degenerated sequence. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056110     DOI: 10.1016/j.bbrc.2009.12.162

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Genome-wide gene expression array identifies novel genes related to disease severity and excessive daytime sleepiness in patients with obstructive sleep apnea.

Authors:  Yung-Che Chen; Kuang-Den Chen; Mao-Chang Su; Chien-Hung Chin; Chung-Jen Chen; Chia-Wei Liou; Ting-Wen Chen; Ya-Chun Chang; Kuo-Tung Huang; Chin-Chou Wang; Ting-Ya Wang; Jen-Chieh Chang; Yong-Yong Lin; Yi-Xin Zheng; Meng-Chih Lin; Chang-Chun Hsiao
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.